Theo Outlook
CoreWeave trades at a $48.1B market cap with TTM revenue of $6.23B and 111.6% YoY quarterly revenue growth, supported by $3.02B EBITDA despite a -$2.65 diluted EPS and -25.6% profit margin. The stock's forward valuation reflects strong GenAI demand, with a price-to-sales ratio of 7.91 and price-to-book of 10.11, positioning it as a high-growth infrastructure play in a rapidly expanding market. Key catalysts include robust analyst support with a $138.37 target price and ratings of 5 Strong Buy plus 21 Buy versus only 2 Sell ratings, alongside continued platform scaling for GenAI workloads and potential market share gains in specialized cloud services. Earnings momentum is evident from the 111.6% revenue surge and gross profit of $4.32B, signaling accelerating adoption and operational leverage as the company expands its data center footprint. Risks center on intense competition from hyperscalers, potential regulatory scrutiny on AI infrastructure, and macroeconomic headwinds affecting capex spending, with the company posting negative operating margins of -6.93%. Mitigations include its specialized GenAI focus, high insider ownership at 18.2%, and institutional backing at 63.6%, which support resilience through targeted product innovation and cost efficiencies. Analysis generated by HeyTheo AI based on SEC filings, earnings transcripts, and market data.
Analysis generated by HeyTheo AI on .





